BPaLM: Overview
- Burden of DR-TB in India
- Types of Drug Resistance Tuberculosis -DRTB
- History of Programmatic Management of Drug Resistant TB [PMDT] in India
- Newer Anti-TB Drugs
- Newer Anti-TB Drugs: Pretomanid [Pa]
- WHO recommendation for newer, shorter, oral regimens
- BPaLM regimen for DR-TB
- Evidence for the efficacy of BPaL regimen in DR-TB
- Rationale for continuation of Moxifloxacin in BPaLM regimen irrespective of FQ resistance
- Shorter oral Bedaquiline-containing MDR/RR-TB regimen
- 2024 NTEG Recommendations for DR-TB Management
- 2024 Updates in DR-TB Management